SynerFuse™ Announces Issuance of Key U.S. Patent on N

MINNEAPOLIS, Feb. 15, 2022 /PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of ...

Related Keywords

Chris Frank , Justin Zenanko , Greg Molnar , Barnes Thornburg , Synerfuse Inc , Us Patent Trademark Office , Trademark Office , Neuromodulation System , Surgically Open Spinal Treatment , Synerfuse Announces Issuance , Novel Use , Chronic Back , Spinal Fixation System , Surgically Open Spinal Treatment Site , Chief Scientific Officer , Fuse Vice President , Intellectual Property , Chronic Lower Back Pain , Failed Back Surgery Syndrome ,